A new international study published in Osteoporosis International and led by Monash's Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent ...
Dementia affects millions of people around the world. It causes problems with memory, thinking, and reasoning. While scientists have studied dementia for many years, they still don’t fully understand ...
The Daily Mail and Alzheimer's Society have launched a drive to defeat dementia, which claims 76,000 lives each year and is ...
Online speculation regarding President Donald Trump's health has intensified after a TikTok creator, citing a post from a ...
MedPage Today on MSN
Alzheimer's benefits may continue after donanemab treatment ends, data suggest
Mean amyloid levels remained below 24.1 centiloids at 3 years for participants who completed donanemab treatment by 1 year.
Shingles and chicken pox are caused by the same virus, herpes zoster. After a chicken pox infection, the virus hides in some ...
The second-most-common form of dementia is Lewy body dementia, said Dr. Jori Fleisher, an associate professor of neurological ...
A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...
Donald Trump appeared drowsy during a Cabinet meeting after a late-night Truth Social spree, prompting online rumors that he ...
The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...
GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...
Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results